Kumar, Mohammad Azhar Uddin, Ayushi Narayan, Mamta Rathore, Nancy Rawat, Ankita Sahu, Yogesh Kumar, Pulkit Hasmukhbhai Leuva, Monika Sharma, Rajesh S, Dwaipayan Saha, Ankita Mridh The Lancet Regional Health - Southeast Asia .2026
But generally, its not a side effect reported in the larger phase 3 trials
It is one of three FDA-approved prescription medications containing semaglutide designed to lower blood sugar levels in adults diagnosed with type 2 diabetes mellitus (T2DM) and known cardiovascular disease
Importantly, patients should follow proper injection technique according to the Instructions for Use, including subcutaneous administration (not intramuscular), site rotation between the abdomen, thigh, or upper arm, and holding the pen in place for the recommended time after injection
It hasnt entirely been published yet, but it was shared out at a cancer conference